Nacuity Pharmaceuticals, Inc.
PrivateLast Round
VC Round
Dec 29, 2025
Total Funding Raised
$46.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nacuity Pharmaceuticals, Inc. is a biopharmaceutical company that develops targeted antioxidant therapies for the treatment of ocular diseases and serious chronic conditions involving oxidative stress.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nacuity Pharmaceuticals, Inc. Comparables
Compare Nacuity Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kiora Pharmaceuticals | 76% | |
| Aldeyra Therapeutics | 76% | |
| Nanoscope Therapeutics Inc. | 73% | |
Nacuity Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 29, 2025 | ||||
| Series B | Jun 15, 2022 | ||||
| Series A Extension | Jan 3, 2022 | ||||
| VC Round | Mar 30, 2021 | ||||
| Series A | Jan 24, 2019 | ||||
Series A | Jan 19, 2017 |
Nacuity Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Series A |
| Tarnagulla Ventures | Series A |
| Foundation Fighting Blindness | Series B, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 39% MoM, from 2.7K to 3.7K.
- Dec 29, 2025
$13M round led by Foundation Fighting Blindness.
Nacuity Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nacuity Pharmaceuticals, Inc.'s valuation, stock price, and market status.